ÂÜÀòÂÒÂ×

Ortal Haviv is the Chief Financial Officer at Neopharm Group, with extensive experience in financial management and accounting roles in various industries such as pharmaceuticals, technology, media, and telecommunications. Ortal has a Master's degree in Law from Bar-Ilan University and a Bachelor's degree in Accounting and Economics, as well as being a Certified Public Accountant (CPA) from Ruppin Academic Center. Ortal's expertise includes financial statements preparation, tax reports, budget management, and risk assessment. Prior to joining Neopharm Group, Ortal worked at LDD Advanced Technologies Ltd, Imagine Media Kids, Cellcom, KPMG Israel, MyInvest, Israel Tax Authority, and the Israel Defense Forces.